Nalaganje...
Chronic treatment with hydroxychloroquine and SARS‐CoV‐2 infection
Hydroxychloroquine sulfate (HCQ) is being scrutinized for repositioning in the treatment and prevention of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. This antimalarial drug is also chronically used to treat patients with autoimmune diseases. By analyzing the Portuguese a...
Shranjeno v:
| izdano v: | J Med Virol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7361589/ https://ncbi.nlm.nih.gov/pubmed/32644224 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.26286 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|